Literature DB >> 23396293

OC125, M11 and OV197 epitopes are not uniformly distributed in the tandem-repeat region of CA125 and require the entire SEA domain.

Alessandro Bressan1, Francesca Bozzo, Carlo Alberto Maggi, Monica Binaschi.   

Abstract

The human cancer antigen 125 (CA125) is over-expressed in epithelial ovarian cancer cells and it plays a role in the pathogenesis of ovarian cancer. This protein presents a repeat region containing up to sixty tandem repeat units. The anti-CA125 monoclonal antibodies have been previously classified into three groups: two major families, the OC125-like antibodies and M11-like antibodies, and a third group, the OV197-like antibodies. A model in which a single repeat unit contains all the epitopes for these antibodies has been also proposed, even if their exact position is still undetermined. In the present work, the affinities of the monoclonal antibodies, representative of the three families, have been investigated for different CA125-recombinant repeats through Western blot analysis. Different patterns of antibody recognition for the recombinant repeats show that CA125 epitopes are not uniformly distributed in the tandem repeat region of the protein. The minimal region for the recognition of these antibodies has been also individuated in the SEA domain through the subcloning of deleted sequences of the highly recognized repeat-25 (R-25), their expression as recombinant fragments in E. coli and Western blot analysis. Obtained data have been further confirmed by ELISA using the entire R-25 as coating antigen.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23396293      PMCID: PMC3810124          DOI: 10.3233/DMA-130968

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  10 in total

1.  Detection of glyco-mucin profiles improves specificity of MUC16 and MUC1 biomarkers in ovarian serous tumours.

Authors:  Sara Ricardo; Lara Marcos-Silva; Daniela Pereira; Rita Pinto; Raquel Almeida; Ola Söderberg; Ulla Mandel; Henrik Clausen; Ana Felix; Nuno Lunet; Leonor David
Journal:  Mol Oncol       Date:  2014-10-22       Impact factor: 6.603

2.  Crystal structure of a human MUC16 SEA domain reveals insight into the nature of the CA125 tumor marker.

Authors:  Brandy White; Michelle Patterson; Saloni Karnwal; Cory L Brooks
Journal:  Proteins       Date:  2022-01-25

3.  Preparative capillary electrophoresis (CE) fractionation of protein digests improves protein and peptide identification in bottom-up proteomics.

Authors:  Simon D Weaver; Naviya Schuster-Little; Rebecca J Whelan
Journal:  Anal Methods       Date:  2022-03-17       Impact factor: 3.532

4.  Mucins MUC16 and MUC1 are major carriers of SLe(a) and SLe(x) in borderline and malignant serous ovarian tumors.

Authors:  Sara Ricardo; Lara Marcos-Silva; Cristina Valente; Ricardo Coelho; Rosa Gomes; Leonor David
Journal:  Virchows Arch       Date:  2016-03-22       Impact factor: 4.064

Review 5.  MUC16 as a novel target for cancer therapy.

Authors:  Abhijit Aithal; Sanchita Rauth; Prakash Kshirsagar; Ashu Shah; Imayavaramban Lakshmanan; Wade M Junker; Maneesh Jain; Moorthy P Ponnusamy; Surinder K Batra
Journal:  Expert Opin Ther Targets       Date:  2018-07-26       Impact factor: 6.902

6.  Selection of DNA Aptamers for Ovarian Cancer Biomarker CA125 Using One-Pot SELEX and High-Throughput Sequencing.

Authors:  Delia J Scoville; Tae Kyu Brian Uhm; Jamie A Shallcross; Rebecca J Whelan
Journal:  J Nucleic Acids       Date:  2017-02-09

Review 7.  Molecular Biomarkers for the Early Detection of Ovarian Cancer.

Authors:  Ruiqian Zhang; Michelle K Y Siu; Hextan Y S Ngan; Karen K L Chan
Journal:  Int J Mol Sci       Date:  2022-10-10       Impact factor: 6.208

8.  Affinity-free enrichment and mass spectrometry analysis of the ovarian cancer biomarker CA125 (MUC16) from patient-derived ascites.

Authors:  Naviya Schuster-Little; Roberta Fritz-Klaus; Mark Etzel; Niharika Patankar; Saahil Javeri; Manish S Patankar; Rebecca J Whelan
Journal:  Analyst       Date:  2021-01-04       Impact factor: 4.616

9.  Membrane-bound mucins of the airway mucosal surfaces are densely decorated with keratan sulfate: revisiting their role in the Lung's innate defense.

Authors:  Jerome Carpenter; Mehmet Kesimer
Journal:  Glycobiology       Date:  2021-05-03       Impact factor: 4.313

Review 10.  MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress.

Authors:  Mildred Felder; Arvinder Kapur; Jesus Gonzalez-Bosquet; Sachi Horibata; Joseph Heintz; Ralph Albrecht; Lucas Fass; Justanjyot Kaur; Kevin Hu; Hadi Shojaei; Rebecca J Whelan; Manish S Patankar
Journal:  Mol Cancer       Date:  2014-05-29       Impact factor: 27.401

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.